There is no official MOTS-c peptide dosage for humans. See what animal studies used, what anecdotal reports claim, and why no safe human dose exists.
There is no officially recognized MOTS-c peptide dosage for humans. MOTS-c is a research-only compound that the FDA has not approved for human use, and no published clinical trial has established a safe or effective dose in people. The numbers circulating online come from animal studies and unverified user reports, not from medical guidance.
What Is MOTS-c Peptide?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a 16-amino-acid peptide encoded inside mitochondrial DNA rather than in the cell nucleus, which makes it unusual among peptides studied for metabolic effects.
Researchers first described MOTS-c in 2015 and reported that it influences insulin sensitivity, glucose handling, and exercise capacity in mice. Because it acts on cellular energy metabolism, it is often discussed alongside other mitochondria-targeted compounds - the same reason questions about ss-31 peptide injection dosage show up in the same forums.
You will also see the spelling MOT-c peptide. Both spellings refer to the same molecule, so searches for mot-c peptide dosage and mots-c peptide human dosage are asking one question.
Is There an Established Human Dose?
No. There is no established MOTS-c peptide human dosage, no recommended starting amount, and no maximum tolerated dose defined in people.
MOTS-c is not FDA-approved for human use in the United States. It is sold as a research chemical, usually labeled 'not for human consumption,' which means no manufacturer is permitted to publish a human dosing schedule for it.
Because there is no human pharmacokinetic data, nobody can say how long MOTS-c stays active in the body, how it is broken down, or what blood levels a given injection produces.
What Doses Have Been Used in Research?
Animal studies have used a wide range of amounts, and those results do not translate directly to humans. Body weight, route of administration, and species differences all change the math.
| Dosing context | Route | Reported amount | Frequency | Evidence level |
|---|---|---|---|---|
| Rodent research | Subcutaneous or intraperitoneal | Study-specific, in the milligram-per-kilogram range | Daily or several times weekly | Preclinical, animals only |
| Anecdotal human reports | Subcutaneous injection | 5-10 mg per injection | 2-5 times per week | Unverified, no trial data |
| Clinical trials in humans | None | None established | None established | No published human dosing studies |
That table is the honest summary: animal work exists, human dosing does not. A milligram-per-kilogram dose in a mouse is not a formula you can scale to a person.
Commonly Reported Anecdotal Human Protocols
Online communities describe several patterns. None of these have been verified in a clinical trial, and they are listed only to explain what people talk about.
- 5 mg three times per week - often described as a starting point in user reports.
- 10 mg twice per week - a higher weekly total, typically split into two injections.
- 5 mg daily for 4-8 weeks - a short run followed by a break.
- Cycling 4-12 weeks on, then 4 weeks off - a pattern borrowed from other research peptides.
Reported weekly totals usually fall between 10 mg and 30 mg. That range is anecdotal, not evidence-based, and it says nothing about safety.
Timing is another variable people argue about constantly. The debate mirrors discussions around when to take aod 9604 peptide, another metabolic research peptide with no approved human protocol.
How MOTS-c Is Typically Handled in Labs
MOTS-c ships as a lyophilized (freeze-dried) powder in a sealed vial. Researchers reconstitute it with bacteriostatic water or sterile saline, then draw amounts with an insulin syringe.
The math is straightforward once you know the concentration. If a 10 mg vial is mixed with 2 mL of water, the solution is 5 mg per mL, so a 5 mg amount equals 1 mL.
| Vial size | Water added | Concentration | 5 mg volume | 10 mg volume |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 0.5 mL | 1 mL |
| 10 mg | 2 mL | 5 mg/mL | 1 mL | 2 mL |
| 10 mg | 3 mL | 3.33 mg/mL | 1.5 mL | 3 mL |
Unit confusion causes most dosing errors. One milligram equals 1,000 micrograms, so 5 mg is 5,000 mcg. On a U-100 insulin syringe, 100 units equals 1 mL.
Safety, Side Effects, and Legal Status
There is no published human safety data for MOTS-c. Long-term effects on mitochondrial function, immune signaling, and hormone regulation are unknown.
Reasonable concerns include injection-site reactions, allergic response to the peptide or the solvent, and the broader risk of injecting an unverified substance. Because mitochondrial peptides influence cellular energy production, unintended metabolic effects cannot be ruled out.
Purity is a real problem. Independent testing of gray-market peptides has repeatedly found underdosed vials, mislabeled compounds, and bacterial contamination. The same purity problem applies whether you are considering MOTS-c or researching where to buy aod-9604 peptide.
Legally, MOTS-c is not approved for any human indication. Selling it for human use is not permitted, and personal possession sits in a gray area that varies by state.
What to Consider Before Any Peptide Protocol
Talk to a licensed healthcare professional before injecting any research peptide. That advice applies to MOTS-c, to any aod 9604 dosage protocol you read about, and to everything else sold online as a research chemical.
Ask what evidence exists, who ran the study, and whether it involved humans. Most peptides in this space have rodent data only, and rodent data does not establish a safe human dose.
People often compare MOTS-c with compounds aimed at metabolism, recovery, or body composition. Searches for hgh peptide dosage tend to come from the same communities, even though growth hormone secretagogues work through very different pathways.
If a supplier cannot provide a third-party certificate of analysis with a batch number, treat the product as unknown.
Key Takeaways on MOTS-c Peptide Dosage
- No regulatory body has approved MOTS-c for human use, and no clinical trial has defined a human dose.
- Animal studies use milligram-per-kilogram amounts that cannot be converted into a safe human amount.
- Anecdotal reports cluster around 5-10 mg per injection, two to five times per week.
- Reconstitution math is simple, but errors between mg and mcg are common.
- Consult a healthcare professional before using any unapproved peptide.
Frequently Asked Questions
What is a typical MOTS-c peptide dosage?
No typical or official dosage exists, because MOTS-c has never been tested in a published human clinical trial. Anecdotal reports from online communities usually describe 5 mg to 10 mg injected subcutaneously two to five times per week, but those numbers are unverified and are not a medical recommendation. Anyone considering it should speak with a licensed healthcare professional first.
Is MOTS-c peptide approved for human use?
No. MOTS-c is not FDA-approved for human use in the United States and is sold only as a research chemical labeled 'not for human consumption.' There is no published human safety data, so long-term effects on metabolism, mitochondrial function, and hormone signaling remain unknown.
How do you reconstitute MOTS-c for research use?
A common approach is to add bacteriostatic water to the lyophilized vial and swirl gently without shaking. A 10 mg vial mixed with 2 mL of water gives a 5 mg/mL concentration, so a 5 mg amount equals 1 mL. Always double-check the math in both milligrams and micrograms before drawing anything.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.